References
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revised (DSM-IV-TR). APA, Washington, DC 2000
- American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry 2001; 158: 1–52
- Chengappa K N, Ebeling T, Kang J S, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry 1999; 60: 477–484
- Citrome L, Krakowski M, Greenberg W M, Andrade E, Volavka J. Antiaggressive effect of quetiapine in a patient with schizoaffective disorder. J Clin Psychiatry 2001; 62: 901
- Clarkin J F, Yeomans F E, Kemberg O F. Psychotherapy for borderline personality. John Wiley & Sons, New York 1999
- Daniel D G. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry 2000; 61: 49–52
- Herpertz S, Sass H, Favazza A. Impulsivity in self-mutilative behavior: psychometric and biological findings. J Psychiatr Res 1997; 31: 451–465
- Kapfhammer H P, Hippius H. Special feature: pharmacotherapy in personality disorders. J Personal Disord 1998; 12: 277–288
- Kapur S, Zipursky R, Jones C, Shammi C S, Remington G, Seeman P. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy. Arch Gen Psychiatry 2000; 57: 553–559
- Kasper S, Muller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother 2000; 1: 783–801
- Kasper S, Tauscher J, Heiden A. Quetiapine: efficacy and tolerability in schizophrenia. Eur Neuropsychopharmacol 2001; 11: 405–413
- Khouzam H R, Donnelly N J. Remission of self-mutilation in a patient with borderline personality during risperidone therapy. J Nerv Ment Dis 1997; 185: 348–349
- Kufferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brucke T, Kasper S. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol. Psychopharmacology 1997; 133: 323–328
- Siever L J, Davis K L. A psychobiological perspective on personality disorders. Am J Psychiatry 1991; 148: 1647–1668
- Simeon D, Stanley B, Frances A, Mann J J, Winchel R, Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry 1992; 149: 221–226
- Soloff P H, Lis J A, Kelly T, Cornelius J, Ulrich R. Risk factors for suicidal behavior in borderline personality disorder. Am J Psychiatry 1994; 151: 1316–1323
- Zanarini M C, Frankenburg F R. Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study. J Clin Psychiatry 2001; 62: 849–854